Femtosecond Laser Arcuate Keratotomy Versus Toric Intraocular Lens Implantation in Cataract Surgery
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jan 11, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods to correct astigmatism during cataract surgery: one method uses a special laser called femtosecond laser arcuate keratotomy, while the other uses a Toric intraocular lens. Astigmatism is a common vision problem that can affect how clearly you see, especially after cataract surgery. The goal of this study is to see which method works better for improving vision quality and patient satisfaction. Participants will have one eye treated with the laser and the other eye fitted with the Toric lens, and their vision will be monitored over time to compare the results.
To be eligible for this trial, you need to be a cataract patient with regular corneal astigmatism between 0.75 and 3.00 diopters, and you should be planning to have femtosecond laser-assisted cataract surgery. Unfortunately, if you have certain eye conditions, past eye surgeries, or severe health issues, you may not qualify. If you join the study, you can expect regular check-ups to assess your vision and how well each treatment is working, helping researchers understand which option could be better for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • cataract patients
- • patients with binocular regular corneal astigmatism ranging from 0.75 to 3.00 D
- • patients who plan to receive femtosecond laser-assisted cataract surgery
- Exclusion Criteria:
- • patients with ocular surface abnormalities such as irregular corneal astigmatism, corneal scarring, keratoconus, and pterygium)
- • patients with history of ocular trauma or surgery
- • patients with coexisting ocular disorders such as glaucoma, retinal vascular occlusive disease, retinal detachment, diabetic retinopathy, and any optic nerve-related pathologies
- • patients with concurrent severe systemic diseases
- • patients who lack of cooperation
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
Ke Yao
Study Chair
Second Affiliated Hospital, School of Medicine, Zhejiang University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported